⌘K

Login Start Free

Home/Filings/4/0001237899-15-000063

4//SEC Filing

REGENERON PHARMACEUTICALS INC 4

Accession 0001237899-15-000063

$REGNCIK 0000872589operating

View on SEC.gov Company Profile

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 4:27 PM ET

Size

10.2 KB

Accession

0001237899-15-000063

Insider Transaction Report

Form 4

Period: 2015-12-16

REGENERON PHARMACEUTICALS INCREGN

SVP Clinical Development

Transactions

Exercise/Conversion
Common Stock
2015-12-16$52.03/sh+1,921$99,950→ 17,742 total
Award
Non-Qualified Stock Option (right to buy)
2015-12-16+25,000→ 25,000 total
Exercise: $555.67Exp: 2025-12-16→ Common Stock (25,000 underlying)
Exercise/Conversion
Incentive Stock Option (right to buy)
2015-12-16−1,921→ 0 total
Exercise: $52.03Exp: 2021-12-16→ Common Stock (1,921 underlying)

Holdings

Common Stock
(indirect: by GRAT)
12,890
Common Stock
(indirect: By 401(k))
1,652

Footnotes (2)

[F1]The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
[F2]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS INC

CIK 0000872589

Entity typeoperating

IncorporatedNY

Related Parties

1

filerCIK 0000872589

Filing Metadata

Form type: 4
Filed: Dec 17, 7:00 PM ET
Accepted: Dec 18, 4:27 PM ET
Size: 10.2 KB

View on SEC.gov